Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Euderma Biotechnology is a China-based dermatology-focused biotech company operating as a subsidiary of Jiaxing TechnoDerma Medicine. Publicly available information indicates the company is active and engaged in biotechnology and medical technology development, drug development-related activities, Class I medical device sales, and import/export. The clearest disclosed commercial product connection is LIQUICURE, a topical nail solution for brittle or damaged nails that TechnoDerma and its Shanghai Euderma subsidiary announced as approved and launched in China. Available sources suggest Euderma functions primarily as a China dermatology commercialization and development vehicle rather than a broad clinical-stage innovator with a disclosed pipeline. Public evidence for additional proprietary pipeline assets, targets, partnerships, investors, or manufacturing infrastructure is limited.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Euderma Biotechnology.